

Michael Osterholm
Director of the Center for Infectious Disease Research and Policy at the University of Minnesota and author of 'The Big One, How We Must Prepare for Future Deadly Pandemics'.
Top 10 podcasts with Michael Osterholm
Ranked by the Snipd community

115 snips
Aug 8, 2025 • 1h 25min
Trump Goes Bananas
Michael Osterholm, the Director of the Center for Infectious Disease Research and Policy, shares insights on the alarming decision to halt federal research into mRNA vaccines. The discussion reveals potential public health crises linked to misinformation and vaccine preparedness. Amid political turmoil, Trump’s chaotic maneuvers are examined, including the fallout from his grand jury investigations and MAGA's redistricting efforts. The dialogue provides a sobering look at the need for political engagement and accountability as the next elections approach.

4 snips
Sep 5, 2025 • 49min
RFK Jr. faces bipartisan backlash at hearing
Michael Osterholm, Director of the University of Minnesota Center for Infectious Disease Research and a prominent public health expert, shares insights on the recent bipartisan backlash against vaccine policies at a Senate hearing. He discusses the critical need for transparent health leadership amidst growing public concerns about COVID-19 data reliability. The conversation also touches on the surprising support for vaccine mandates among Republicans and highlights challenges in national pandemic preparedness, warning of potential future health crises.

Apr 30, 2024 • 31min
What You Need to Know About Bird Flu
Prof. Michael Osterholm discusses bird flu in US dairy cows, its potential to spread to humans, and the risks of consumption. Insights on virus evolution, cross-species transmission, outbreak detection challenges, and precautions for the public. Emphasis on pandemic preparedness and surveillance in farm animals.

Aug 21, 2025 • 56min
Leading Pediatric Group Splits with CDC Over Vaccine Recommendations
Michael Osterholm, a renowned epidemiologist and director of the Center for Infectious Disease Research and Policy, discusses the American Academy of Pediatrics' surprising decision to continue recommending COVID-19 vaccines for young children, diverging from CDC guidance. He addresses the implications of federal cuts to vaccine research funding and critiques the motivations behind conflicting health messages. Osterholm emphasizes the urgency for transparency in discussing vaccine safety and the importance of mRNA technology in preparing for future pandemics.

Aug 12, 2025 • 25min
HHS & mRNA Vaccines Research Cuts
Michael Osterholm, Director of CIDRAP and author of The Big One, shares insights on recent cuts to mRNA vaccine funding and their implications for public health. He emphasizes the critical role of mRNA technology beyond COVID-19, discusses the troubling impact of misinformation on vaccine perceptions, and highlights the need for scientific integrity in vaccination efforts. Osterholm also initiates the Vaccine Integrity Project to enhance public understanding of vaccine efficacy, analyzing extensive research data to combat skepticism.

Jun 10, 2025 • 31min
Information Inoculation: Defending Against Medical Myths: Why do you need to get a flu shot every year? | Melvin Sanicas
Michael Osterholm, a renowned epidemiologist and director at the University of Minnesota's Center for Infectious Disease Research and Policy, joins Melvin Sanicas to tackle pressing public health issues. They dive into why flu vaccines require annual updates due to the virus's rapid mutations. The conversation highlights the dangers of misinformation about vaccines and emphasizes the crucial role of accurate data and communication in rebuilding public trust. Listeners discover the importance of community preparedness against future pandemics.

May 28, 2025 • 28min
Could The NIH Plan For A ‘Universal Vaccine’ Really Work?
Join infectious disease expert Michael Osterholm and vaccine researcher Ted Ross as they delve into the NIH's ambitious plan for a universal vaccine. They discuss the potential of a single shot for flu and COVID-19 that could last for years. The conversation covers the challenges of vaccine development, addressing public hesitancy, and the innovative COBRA program that uses AI in vaccine design. With clinical trials on the horizon, they explore the complexities of ensuring trust and efficacy in public health strategies.

Dec 5, 2024 • 30min
In Good Health: Vaccine Hesitancy, Flu Season, And A Second Trump Presidency
Michael Osterholm, an infectious disease expert from the University of Minnesota, joins health politics reporter Dan Diamond and vaccine specialist Dr. Haley Gans from Stanford. They dive into the troubling low vaccination rates as flu season approaches, discussing the critical need for community efforts. The guests explore the increasing vaccine hesitancy influenced by mixed messages around COVID-19 and potential health policies under the incoming Trump administration, raising concerns over misinformation and public health risks.

Feb 18, 2022 • 2h 32min
#1779 - Michael Osterholm
Dr. Michael Osterholm, a renowned expert in infectious disease epidemiology, dives into the complexities of the COVID-19 pandemic. He discusses the impact of misinformation and highlights how COVID-19 variants, especially in wildlife, complicate management efforts. Osterholm explores the origins of SARS-CoV, emphasizing the need for transparency in research. He also examines long COVID, health disparities tied to vitamin D, and the role of barbershops in community health education. The conversation underscores the importance of humility in public health communication.

Mar 31, 2020 • 1h 22min
#102 - Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concern
Michael Osterholm, Director of the Center for Infectious Disease Research and Policy at the University of Minnesota, shares invaluable insights on COVID-19. He discusses the true case fatality rate and how factors like obesity influence outcomes. Michael highlights the importance of immunity and cautions about supply chain issues affecting vaccines and testing. He also reflects on future protection strategies for healthcare workers and the long-term health implications for COVID survivors. His perspective balances optimism with the challenges still ahead.